查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495344

等溫核酸擴增技術 (INAAT) 市場：2024-2033 年全球產業分析、規模、佔有率、成長、趨勢、預測

Isothermal Nucleic Acid Amplification Technology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 342 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究對等溫核酸擴增技術 (INAAT) 市場進行了詳細分析，提供了對其複雜動態和未來發展軌蹟的見解。從市場趨勢到成長催化劑、抑制劑和新興模式，我們提供 2024 年至 2033 年有價值的統計數據和預測。

關鍵見解

  • INAAT 市場規模（2024 年）：52.6 億美元
  • 市場預測（2033 年）：145.6 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：12.0%

INAAT 市場 - 報告範圍：

INAAT 市場涵蓋醫療保健、製藥和生物技術等行業的各種應用。 INAAT廣泛用於快速、準確的核酸檢測，對於疾病診斷、病原體檢測和基因檢測至關重要。該市場服務於廣泛的最終用戶，包括醫院、診斷實驗室、研究機構和生物製藥公司，並提供具有多種臨床和研究應用的高度通用的技術。市場成長是由技術進步、對即時診斷的需求不斷增加以及傳染病流行等因素所推動的。

市場驅動因素：

全球 INAAT 市場受到幾個關鍵成長動力的支持。分子診斷技術的進步將提高 INAAT 的效率和應用，並促進其在各行業的採用。此外，對現場診斷的需求不斷增長，尤其是在新興國家，對 INAAT 作為快速、準確疾病檢測的關鍵技術產生了巨大的需求。此外，人們越來越重視傳染病的早期和準確診斷，這促使了研發活動的增加以及新型 INAAT 平台和檢測方法的開發。

市場限制因素：

儘管 INAAT 市場成長前景廣闊，但仍面臨監管合規、替代技術競爭和高成本等課題。診斷技術的嚴格監管要求給製造商和最終用戶帶來了合規負擔，影響了市場擴張。此外，來自PCR等其他核酸擴增技術的競爭對INAAT的廣泛使用提出了課題。此外，與 INAAT 平台和試劑相關的高成本可能會影響市場成長，因此需要開發具有成本效益的解決方案。

市場機會：

INAAT 市場透過技術創新、產業聯盟和市場多元化提供了利潤豐厚的成長機會。個人化醫療、傳染病流行和基因研究進展等新趨勢正在促使製造商探索 INAAT 在臨床和研究環境中的新用途和配方。此外，透過策略合作夥伴關係、研究合作和併購，市場參與者正在擴大其產品組合，增強其技術能力，並加強其在關鍵地區的市場佔有率。此外，增加研發投資以及政府加強對創新和醫療基礎設施的支持正在創造一個有利於市場擴張和多元化的環境。

本報告涵蓋的主要問題

  • 推動 INAAT 市場全球成長的關鍵因素是什麼？
  • 技術進步和產業趨勢如何影響 INAAT 應用和配方的演變？
  • INAAT 產業的市場參與者面臨哪些主要課題和機會？
  • 哪些產業和地區對 INAAT 製造商來說最具成長潛力？
  • 領先公司正在採取哪些策略來使其 INAAT 產品脫穎而出並在競爭格局中獲得市場佔有率？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第三章市場背景

  • 市場動態
  • 情境預測
  • 機會圖分析
  • 投資可行性矩陣
  • PESTLE 和 Porter 分析
  • 監理狀況
  • 區域母公司市場前景

第四章全球等溫核酸擴增技術（INAAT）市場分析

  • 過去的市場規模價值（金額）分析，2019-2023 年
  • 2024-2033 年當前及未來市場規模價值（金額）預測
    • 年成長趨勢分析
    • 絕對利潤機會分析

第五章全球等溫核酸擴增技術 (INAAT) 市場分析：依產品

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023 年
  • 2024-2033 年當前與未來市場規模（金額）分析與預測
    • 設備
    • 試劑
  • 2019-2023 年年成長趨勢分析
  • 2024-2033 年絕對獲利機會分析

第六章全球等溫核酸擴增技術 (INAAT) 市場分析：依技術分類

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023 年
  • 2024-2033 年當前與未來市場規模（金額）分析與預測
    • NASBA
    • 哈德
    • 燈
    • SDA
    • SPIA
    • 近
    • TMA
    • RCA
    • 機器人流程自動化
    • SMAP2
    • 其他
  • 2019-2023 年年成長趨勢分析
  • 2024-2033 年絕對獲利機會分析

第 7 章全球等溫核酸擴增技術 (INAAT) 市場分析：依應用分類

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023 年
  • 2024-2033 年當前與未來市場規模（金額）分析與預測
    • 驗血
    • 傳染病診斷
    • 癌症
    • 其他
  • 2019-2023 年年成長趨勢分析
  • 2024-2033 年絕對獲利機會分析

第 8 章全球等溫核酸擴增技術 (INAAT) 市場分析：依最終用途劃分

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023 年
  • 2024-2033 年當前與未來市場規模（金額）分析與預測
    • 醫院
    • 中心實驗室與參考實驗室
    • 其他
  • 2019-2023 年年成長趨勢分析
  • 2024-2033 年絕對獲利機會分析

第九章全球等溫核酸擴增技術 (INAAT) 市場依地區分析

  • 簡介
  • 過去的市場規模（金額）分析，2019-2023 年
  • 目前市場規模（金額）分析與預測，2024-2033 年
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 區域市場吸引力分析

第十章北美等溫核酸擴增技術（INAAT）市場分析（依國家）

第 11 章拉丁美洲等溫核酸擴增技術 (INAAT) 市場分析（依國家）

第十二章歐洲等溫核酸擴增技術（INAAT）市場分析（依國家）

第十三章亞太地區等溫核酸擴增技術 (INAAT) 市場分析（依國家）

第十四章中東與非洲等溫核酸擴增技術 (INAAT) 市場分析

第十五章主要國家等溫核酸擴增技術（INAAT）市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 中國
  • 日本
  • 韓國
  • 馬來西亞
  • 新加坡
  • 澳大利亞
  • 紐西蘭
  • 海灣合作委員會國家
  • 南非
  • 以色列

第十六章市場結構分析

  • 競爭對手儀表板
  • 競爭基準
  • 主要公司市佔率分析

第十七章競爭分析

  • 衝突詳情
    • Alere, Inc.
    • bioMerieux SA
    • Eiken Chemical Co. Ltd
    • Hologic Inc.（Gen-Probe）
    • Lucigen
    • Meridian Bioscience, Inc.
    • Ustar Biotechnologies Ltd.
    • QIAGEN
    • Quidel Corporation
    • Thermo Fisher Scientific, Inc.
    • BD（Becton, Dickinson &Company）

第 18 章先決條件與使用的縮寫

第 19 章研究方法

簡介目錄
Product Code: PMRREP33206

Persistence Market Research presents an in-depth analysis of the Isothermal Nucleic Acid Amplification Technology (INAAT) Market, offering insights into its intricate dynamics and future trajectory. From market trends to growth catalysts, impediments, and emerging patterns, this report furnishes invaluable statistics and projections spanning from 2024 to 2033.

Key Insights:

  • INAAT Market Size (2024): USD 5.26 Billion
  • Projected Market Value (2033): USD 14.56 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 12.0%

INAAT Market - Report Scope:

The INAAT Market encompasses various applications across industries such as healthcare, pharmaceuticals, and biotechnology. INAAT is widely used for the rapid and accurate detection of nucleic acids, making it essential in disease diagnostics, pathogen detection, and genetic testing. This market caters to a wide range of end-users, including hospitals, diagnostic laboratories, research institutes, and biopharmaceutical companies, offering a versatile technology with numerous clinical and research applications. Market growth is driven by factors such as technological advancements, increasing demand for point-of-care diagnostics, and the rising prevalence of infectious diseases.

Market Growth Drivers:

The global INAAT Market is bolstered by several key growth drivers. Technological advancements in molecular diagnostics enhance the efficiency and applications of INAAT, driving its adoption across various industries. Moreover, the increasing demand for point-of-care diagnostics, especially in emerging economies, creates significant demand for INAAT as a key technology for rapid and accurate disease detection. Additionally, the growing emphasis on early and precise diagnosis of infectious diseases stimulates research and development activities, leading to the development of novel INAAT platforms and assays.

Market Restraints:

Despite its promising growth prospects, the INAAT Market faces challenges related to regulatory compliance, competition from alternative technologies, and high costs. Stringent regulatory requirements regarding diagnostic technologies impose compliance burdens on manufacturers and end-users, impacting market expansion. Furthermore, competition from other nucleic acid amplification technologies, such as PCR, poses challenges to the widespread adoption of INAAT. Additionally, the high costs associated with INAAT platforms and reagents can affect market growth, necessitating the development of cost-effective solutions.

Market Opportunities:

The INAAT Market presents lucrative growth opportunities driven by technological innovation, industry collaborations, and market diversification. Emerging trends such as personalized medicine, infectious disease outbreaks, and advancements in genetic research inspire manufacturers to explore new applications and formulations for INAAT in clinical and research settings. Moreover, strategic partnerships, research collaborations, and mergers and acquisitions enable market players to expand their product portfolios, enhance their technical capabilities, and strengthen their market presence in key regions. Furthermore, growing investments in research and development, coupled with increasing government support for innovation and healthcare infrastructure, create a conducive environment for market expansion and diversification.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the INAAT Market globally?
  • How are technological advancements and industry trends shaping the evolution of INAAT applications and formulations?
  • What are the key challenges and opportunities facing market participants in the INAAT segment?
  • Which industrial sectors and geographic regions offer the highest growth potential for INAAT manufacturers?
  • What strategies are leading companies employing to differentiate their INAAT offerings and capture market share in the competitive diagnostic landscape?

Competitive Intelligence and Business Strategy:

Leading players in the global INAAT Market, including diagnostic companies, pharmaceutical firms, and biotechnology enterprises, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop advanced INAAT technologies, improve product quality, and explore new applications for INAAT in various industries. Moreover, strategic collaborations with research institutions, academic partners, and industry associations enable market players to access new technologies, expand their knowledge base, and accelerate product development efforts. Furthermore, emphasis on regulatory compliance, quality assurance, and customer support enhances brand reputation and fosters long-term relationships with customers and stakeholders.

Key Companies Profiled:

  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.(Gen-Probe)
  • Lucigen
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD (Becton, Dickinson & Company)
  • OptiGene Limited

INAAT Market Research Segmentation:

By Product Type

  • Instruments
  • Reagent

By Technology

  • NASBA
  • HDA
  • LAMP
  • SDA
  • SPIA
  • NEAR
  • TMA
  • RCA
  • RPA
  • SMAP2
  • Others

By Application

  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • Others

By End User

  • Hospitals
  • Central & Reference Labs
  • Others

By Region

  • North America Market
  • Europe Market
  • Asia Pacific Market
  • Middle East & Africa Market
  • South America Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast, 2024-2033

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Product , 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product , 2024-2033
    • 5.3.1. Instruments
    • 5.3.2. Reagent
  • 5.4. Y-o-Y Growth Trend Analysis By Product , 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product , 2024-2033

6. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Technology

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Technology, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Technology, 2024-2033
    • 6.3.1. NASBA
    • 6.3.2. HAD
    • 6.3.3. LAMP
    • 6.3.4. SDA
    • 6.3.5. SPIA
    • 6.3.6. NEAR
    • 6.3.7. TMA
    • 6.3.8. RCA
    • 6.3.9. RPA
    • 6.3.10. SMAP2
    • 6.3.11. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Technology, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Technology, 2024-2033

7. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Bn) Analysis By Application , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application , 2024-2033
    • 7.3.1. Blood Screening
    • 7.3.2. Infectious Disease Diagnostics
    • 7.3.3. Cancer
    • 7.3.4. Others
  • 7.4. Y-o-Y Growth Trend Analysis By Application , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application , 2024-2033

8. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By End-use

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Bn) Analysis By End-use, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-use, 2024-2033
    • 8.3.1. Hospitals
    • 8.3.2. Central & Reference Labs
    • 8.3.3. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End-use, 2024-2033

9. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End-use
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Technology
    • 10.3.4. By Application
    • 10.3.5. By End-use
  • 10.4. Key Takeaways

11. Latin America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By End-use
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Technology
    • 11.3.4. By Application
    • 11.3.5. By End-use
  • 11.4. Key Takeaways

12. Europe Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Technology
    • 12.2.4. By Application
    • 12.2.5. By End-use
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Technology
    • 12.3.4. By Application
    • 12.3.5. By End-use
  • 12.4. Key Takeaways

13. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. India
      • 13.2.1.5. Malaysia
      • 13.2.1.6. Singapore
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of APAC
    • 13.2.2. By Product
    • 13.2.3. By Technology
    • 13.2.4. By Application
    • 13.2.5. By End-use
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Technology
    • 13.3.4. By Application
    • 13.3.5. By End-use
  • 13.4. Key Takeaways

14. MEA Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Technology
    • 14.2.4. By Application
    • 14.2.5. By End-use
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Technology
    • 14.3.4. By Application
    • 14.3.5. By End-use
  • 14.4. Key Takeaways

15. Key Countries Isothermal Nucleic Acid Amplification Technology Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Technology
      • 15.1.2.3. By Application
      • 15.1.2.4. By End-use
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Technology
      • 15.2.2.3. By Application
      • 15.2.2.4. By End-use
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Technology
      • 15.3.2.3. By Application
      • 15.3.2.4. By End-use
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Technology
      • 15.4.2.3. By Application
      • 15.4.2.4. By End-use
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Technology
      • 15.5.2.3. By Application
      • 15.5.2.4. By End-use
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Technology
      • 15.6.2.3. By Application
      • 15.6.2.4. By End-use
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Technology
      • 15.7.2.3. By Application
      • 15.7.2.4. By End-use
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Technology
      • 15.8.2.3. By Application
      • 15.8.2.4. By End-use
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Technology
      • 15.9.2.3. By Application
      • 15.9.2.4. By End-use
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Technology
      • 15.10.2.3. By Application
      • 15.10.2.4. By End-use
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Technology
      • 15.11.2.3. By Application
      • 15.11.2.4. By End-use
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Technology
      • 15.12.2.3. By Application
      • 15.12.2.4. By End-use
  • 15.13. Malaysia
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Technology
      • 15.13.2.3. By Application
      • 15.13.2.4. By End-use
  • 15.14. Singapore
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Technology
      • 15.14.2.3. By Application
      • 15.14.2.4. By End-use
  • 15.15. Australia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Technology
      • 15.15.2.3. By Application
      • 15.15.2.4. By End-use
  • 15.16. New Zealand
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Technology
      • 15.16.2.3. By Application
      • 15.16.2.4. By End-use
  • 15.17. GCC Countries
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Technology
      • 15.17.2.3. By Application
      • 15.17.2.4. By End-use
  • 15.18. South Africa
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Technology
      • 15.18.2.3. By Application
      • 15.18.2.4. By End-use
  • 15.19. Israel
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Technology
      • 15.19.2.3. By Application
      • 15.19.2.4. By End-use

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Technology
    • 16.3.4. By Application
    • 16.3.5. By End-use

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. Alere, Inc.
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. bioMerieux SA
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. Eiken Chemical Co. Ltd
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Hologic Inc.(Gen-Probe)
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. Lucigen
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Meridian Bioscience, Inc.
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Ustar Biotechnologies Ltd.
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. QIAGEN
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. Quidel Corporation
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Thermo Fisher Scientific, Inc.
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy
    • 17.1.11. BD (Becton, Dickinson & Company)
      • 17.1.11.1. Overview
      • 17.1.11.2. Product Portfolio
      • 17.1.11.3. Profitability by Market Segments
      • 17.1.11.4. Sales Footprint
      • 17.1.11.5. Strategy Overview
        • 17.1.11.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology